February 2, 2017
Novo Nordisk reports 9% net profit increase
Novo Nordisk has reported net profit increased by 9% to Eur 5,1 billion. Diluted earnings per share increased by 11% to Eur 2,01.
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
February 2, 2017
Stem cell transplants may induce long-term remission of multiple sclerosis
New clinical trial results provide evidence that high-dose immunosuppressive therapy followed by transplantation of a person’s own blood-forming stem cells can induce sustained remission of relapsing-remitting multiple sclerosis (MS), an autoimmune disease in which the immune system attacks the central nervous system.
February 2, 2017
Diplomat pharmacy wraps up $20million Affinity Biotech purchase
Diplomat Pharmacy has concluded the purchase of a Houston based pharmacy and infusion services specialist Affinity Biotech, which focuses on treating patients with hemophilia.
February 1, 2017
Pfizers full years earnings up 4%, Q1 2017 dividend rise 7%
Pfizer has reported 11% growth for full-year 2016 revenues, reaching $52.8 billion, including the business from Hospira and the legacy of Medivation. Net income for full year was $7,215 million which is up 4% from last years total net income of $6,960.
February 1, 2017
Allergan completes $2.9 LifeCell buy, boosts up its plastic surgery business
Allergan has completed the $2.9 billion purchase of Acelity’s subsidiary LifeCell, adding commercial products to its regenerative medicine portfolio, and LifeCell’s innovative manufacturing capabilities and its R&D operations, based in New Jersey.
February 1, 2017
Medivir studies potentially $6 billion annually worth drug
Data Monitoring Committee (DMC) held its fourth and final scheduled meeting and recommended continuation of the ongoing randomized, double-blind phase IIa study of Medivir’s MIV-711 in patients with moderate knee osteoarthritis.
February 1, 2017
Biomarin’s hemophilia drug nets PRIME status in Europe
BioMarin Pharmaceutical’s treatment for hemophilia has been accepted for PRIME (Priority Medicines) scheme from the European Medicines Agency (EMA).
February 1, 2017
Ineos Styrolution presents two new styrenics grades at Pharmapack 2017, Paris
INEOS Styrolution, the global player in styrenics, has announced two new styrenics grades, both of which designed for very specific use by medical device manufacturers.
February 1, 2017
INTERVIEW: Anne Schumacher, Brand Director at Pharmapack Europe, 20 years of Pharmapack
Pharmapack 2017, kicking off on February 1, 2017 marks 20 years of Pharmapack. We talked with Anne Schumacher, Brand Director at Pharmapack Europe.
February 1, 2017
Allergy Therapeutics’s peanut allergy vaccine research shows positive results
Allergy Therapeutics, a pharmaceutical company specialising in allergy vaccines, has announced positive results from preclinical research of its therapeutic peanut allergy vaccine, Polyvac Peanut.